Related Experiment Video
Updated: Jan 15, 2026
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
A simple formula for predicting the warfarin dose in atrial fibrillation: development, external validation, and model
Anunya Ujjin1,2, Natnicha Pongbangli3, Wanwarang Wongcharoen4
1Division of Medicine, Neurological Institute of Thailand, Bangkok, Thailand.
Background:
The dose of warfarin varies between individuals. Several formulas for predicting the maintenance dose of warfarin have been developed; however, most are complicated and not practical for clinical use.
Objective:
To determine factors that predict warfarin dosage and the relationship between clinical variables and the maintenance dose of warfarin, and to develop a simple formula for predicting the maintenance dose of warfarin that is particularly useful for identifying patients with atrial fibrillation (AF) who are at higher risk of bleeding, without relying on pharmacogenetic data.
Materials And Methods:
This was a retrospective cohort study carried out between 2011 and 2021. All patients are started on warfarin with a target INR of 2.0 to 3.0. The prediction models for the maintenance dose were developed using a first-order equation. Correlation and performance of the formula were examined in training and validation cohorts.
Results:
A training cohort consisted of 520 patients with a mean age of 69 ± 12 years. The proposed warfarin dosing formula was 3+(0.02×body weight (kg))-(0.02×age (years))-(0.4×serum creatinine (mg/dL)).When compared with a warfarin dosing formula, a 3-mg dose was associated with overdosing with an odds ratio [OR] of 3.31 (95%CI 2.26-4.84, p < 0.0001) in patients whose body weight was < 60 kg, OR 3.08 (95%CI 2.15-4.40, p < 0.0001) in patients aged ≥ 70 years and OR 2.39 (95% CI 1.67-3.44, p < 0.0001) in patients with eGFR < 50 mL/min. The findings in the validation cohort of 632 patients were concordant with the training cohort.
Conclusion:
A simple warfarin dosing formula incorporating age, body weight, and serum creatinine reduced the risk of warfarin overdose in a high-risk population.
Related Concept Videos
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:26Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
01:29Venous Thrombosis III: Interprofessional Care
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
01:14Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
01:20Estimation of k and VD of Aminoglycosides